Why Emergent BioSciences Stock Plummeted Today [Yahoo! Finance]
Emergent BioSolutions Inc. (EBS)
Last emergent biosolutions inc. earnings: 4/30 04:08 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.emergentbiosolutions.com
Company Research
Source: Yahoo! Finance
The vaccine maker divulged in a regulatory filing that several institutional share and warrant holders are selling such securities. Investors reacted by trading Emergent's stock down by almost 6%, on a day when the S&P 500 (SNPINDEX: ^GSPC) more or less flatlined. The selling parties are mainly entities affiliated with OHA Agency, a business that provided a $250 million term loan to Emergent in August. In return for this, the vaccine maker issued slightly over 1.1 million shares of its common stock to OHA, plus 2.5 million warrants to buy said stock. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free » In the sale, the sellers will divest up to a bit over 3.6 million Emergent shares. That amount includes the 1.1 million issued shares, plus shares deriving from exercise of the warrants. The company said that the sales would be effected from time to time, and did not provide further details. Emergent stressed in its filing t
Show less
Read more
Impact Snapshot
Event Time:
EBS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EBS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EBS alerts
High impacting Emergent BioSolutions Inc. news events
Weekly update
A roundup of the hottest topics
EBS
News
- Emergent BioSolutions Inc. (NYSE: EBS) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted) [Yahoo! Finance]Yahoo! Finance
- Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)GlobeNewswire
- Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- 2-Day Virtual Aseptic Processing of Pharmaceutical and Biotech Products Course [Yahoo! Finance]Yahoo! Finance
EBS
Earnings
- 11/6/24 - Beat
EBS
Sec Filings
- 12/17/24 - Form 4
- 12/10/24 - Form 4
- 12/5/24 - Form EFFECT
- EBS's page on the SEC website